SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
651 David, I couldn't pull up last qs press release. Do you remember what SalaVector1-2/11/1998
650 Thanks, David. [eom]lrb-2/11/1998
649 << Anyone been to one of them-there "investor breakfasts" latelDavid Cathcart-2/11/1998
648 Anyone been to one of them-there "investor breakfasts" lately where Blrb-2/11/1998
647 Thanks, David. The details of the report made very pleasant reading to me. SeemDan Lazare-2/11/1998
646 A loss of 2 cents for the quarter. Not as good as I expected but the coming yeDavid Cathcart-2/11/1998
645 Thanks, David. We'll be watching closely on Wednesday. Dan LazareDan Lazare-2/8/1998
644 Glenn, Since this reporting quarter is the year-end, they are taking a little David Cathcart-2/6/1998
643 Peter I now think this old data was material presented as a poster only at thiseminole-2/6/1998
642 Shouldn't MGI have posted quarterly financials by now? Did I miss it? ThaGlenn W-2/6/1998
641 Richard, I don't think I've seen this abstract before, so even though Biomaven-2/6/1998
640 David, Thanks for your response. I think you are right - the "new" aBiomaven-2/6/1998
639 Peter The reference I posted was very old data. The data was presented last Aseminole-2/6/1998
638 Peter, On December 4th I posted information from a presentation given by ChucDavid Cathcart-2/6/1998
637 Richard - I'm confused with the info in the reference you cited. Compare Biomaven-2/6/1998
636 MGI FANS I am hoping we get some clinical trial information next week. Here iseminole-2/5/1998
635 Glenn Yes, the NCI should provide most of the funding but in the last conferenseminole-2/3/1998
634 > But the Euro partner would need to provide the funds for Phase II testing Glenn W-2/3/1998
633 Adam Yes, I think $12/sh is possible this year if everything goes as you haveseminole-2/3/1998
632 Are we going to know this qtr if Mogn is moving onto to Phase 2 in MGI 114,and adam hefian-2/2/1998
631 Is that in a paperback? astroastro-2/2/1998
630 David <<<<MGI Pharma is not an easy story to understand>>>seminole-2/2/1998
629 Richard, In my conversation with Lori last week, she said that quite a few broDavid Cathcart-2/2/1998
628 Maybe the broker who is following MOGN has a family...[EOM]David Cathcart-2/2/1998
627 Irb From: Annual Report 1996 "MGI 114 is the lead compound from a family seminole-2/2/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News